Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

By afschroeder • October 24, 2025

Augustin M, Armstrong A, Issa NT, Petersen AS, von Eyben R, Festini T, Torres T. Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis. Dermatol Ther (Heidelb). 2025 Oct 23. doi: 10.1007/s13555-025-01563-3. Epub ahead of print. PMID: 41131441.

Tags: atopic dermatitis, Dermatology, lebrikizumab, Long-term disease management, Maintenance of efficacy, Matching-adjusted indirect comparison, Publications, Tralokinumab

Photosensitive symmetric papules of the nasal alae

Peng DS, Dong E, Seivright J, Gates G, Nguyen MO. Photosensitive symmetric papules of the nasal alae. JAAD Case Rep. 2026 Jan 21;70:253-255. doi: 10.1016/j.jdcr.2026.01.017.[...]

International development of Investigator Global Assessment scores for pemphigus

Murrell DF, Boucher D, Daneshpazhooh M, Mahmoudi H, Kianfar N, Dasdar S, Yale M, Wilson A, Bilgic A, Uzun S, Chandran NS, Patsatsi A, Drenovska[...]

Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative Review

Armstrong AW, Krueger JG, Strober BE, Stein Gold LF, Desai SR, Muscianisi E, Klyachkin Y, Ucpinar S, Tilley MK, Blauvelt A. Envudeucitinib, a Potent, Next-Generation,[...]